Inspection Findings:
2. Resident 1 was admitted to the facility in 11/2023 with diagnoses including Parkinson's disease, cerebrovascular disease and neurogenic bladder. The resident's 03/01/24 to 03/11/24 MARs and signed physician orders dated 11/22/23 were reviewed. The following was identified:* The facility was administering sertraline (an antidepressant medication) - 2 tablets every day. The facility did not have a written, signed physician order documented in the resident's facility record.* The facility was administering azelastine nasal spray (for symptoms of rhinitis) - 2 sprays twice daily. The current physician order in the resident's record, dated 11/22/23, directed the facility to administer 2 sprays once daily. The facility did not have a written, signed physician order for the increased dosage documented in the resident's facility record. The need to ensure the facility had written, signed physician orders documented in the resident's facility record was reviewed with Staff 1 (Administrator), Staff 2 (Assisted Living Coordinator), Staff 3 (MCC Administrator) and Staff 16 (Wellness Director) on 03/15/24. They acknowledged the findings.3. Resident 2 was admitted to the facility in 01/2024 with diagnoses including Parkinson's disease, hemiplegia affecting non-dominant side and memory impairment. The resident's 02/01/24 to 03/11/24 MARs and physician orders dated 01/05/24 and subsequent orders were reviewed. The following was identified:a. The 01/05/24 physician order list the facility obtained at Resident 2's admission was not signed by an authorized prescriber. Therefore, the facility had no signed physician orders to administer any of the medications it was administering to Resident 2 between 01/04/24 and 03/11/24.b. The facility lacked orders for the following additional medications being administered by the facility:* Cranberry PAC (for urinary tract health) 36 mg capsules - 1 capsule daily;* Estrace cream (for symptoms of menopause) - apply 3 times weekly;* Preservision gel (for eye health) - 1 gel daily;* Acetaminophen 325 mg tablet - 2 tablets every 4 hours as needed for pain; and* Melatonin 3 mg tablet - 1 tablet nightly as needed for insomnia.c. Between 02/01/24 and 03/11/24, the following medications were not administered as prescribed due to the "medication not available":* Baclofen TID (to relieve muscle spasms and tightness) all three times on 03/05/24;* Cultrelle once daily (for digestive health) on 03/01/24, 03/02/24 and 03/03/24;* Ezetimide once daily (for high cholesterol) on 02/29/24, 03/01/24, 03/02/24, 03/03/24, 03/07/24 and 03/08/24;* Modafinil once daily (to treat excessive daytime sleepiness) on 02/21/24;* Preservision gels once daily (for eye health) on 02/06/24 through 02/11/24 and 02/12/24 through 02/17/24; and* Vitamin D3 once every other day (supplement for calcium and phosphate absorption) on 03/01/24 and 03/03/24.The need to ensure the facility had written, signed physician orders documented in the resident's facility record and all medication orders were carried out as prescribed was reviewed with Staff 1 (Administrator), Staff 2 (Assisted Living Coordinator), Staff 3 (MCC Administrator) and Staff 16 (Wellness Director) on 03/15/24. They acknowledged the findings.
Based on interview and record review, it was determined the facility failed to ensure medication orders were carried out as prescribed, and written, signed physician or other legally recognized practitioner orders were documented in the resident's facility record for all medications the facility was responsible for administering for 3 of 3 sampled residents (#s 1, 2, and 3) whose records were reviewed. Findings include, but are not limited to:1. Resident 3 was admitted to the facility in 08/2023 with diagnoses including Type 2 diabetes and hypertension. The resident's 02/01/24 to 03/11/24 MARs and physician orders dated 07/19/23 were reviewed, and the following was identified:a. The resident's MAR indicated the following medications were not administered:* Metformin (for Type 2 diabetes) on 03/02/24; and* Losartan (for hypertension) on 03/03/24 and 03/05/24.During an interview at 3:42 pm on 03/13/24, Staff 12 (MT) confirmed Med Techs were supposed to reorder medications, and that the above medications had not been reordered timely.b. The resident had an order for polyethylene glycol, take 17 grams by mouth daily for bowel care. Review of the MAR revealed the medication was listed as a PRN. During an interview at 3:42 pm on 03/13/24, Staff 12 confirmed the medication was not being administered daily.c. The following medications that were being administered by the facility lacked signed physician or other legally recognized practitioner orders:* Naproxen PRN (for pain);* Hydrocodone acetaminophen PRN (for pain);* Benzonatate PRN (for cough); and* Fexofendine (for allergies).The need to ensure orders were carried out as prescribed and written signed physician or other legally recognized practitioner orders were documented in the resident's record was discussed on 03/15/24 with Staff 1 (Administrator), Staff 2 (Assisted Living Coordinator), Staff 3 (MCC Administrator), and Staff 16 (Wellness Director). They acknowledged the findings.
Based on interview and record review, it was determined the facility failed to ensure physician or other legally recognized practitioner orders were carried out as prescribed for 2 of 2 sampled residents (#s 5 and 6) whose orders were reviewed. This is a repeat citation. Findings include, but are not limited to:1. Resident 6 moved into the facility in 04/2024 with diagnoses including type 2 diabetes mellitus and hypertension (high blood pressure).The resident's MAR dated 08/01/24 through 09/02/24 and current physician's orders were reviewed.The resident had physician orders for the following medications dated 05/07/24:* Aspirin 81 mg - Chew one tablet by oral route everyday (for stroke prevention);* Atorvastatin 40 mg - Take one tablet by mouth daily (for high cholesterol);* Lisinopril-HCTZ 20-12.5 mg - Take one tablet by mouth twice a day (for high cholesterol); and* Metformin 1000 mg - Take one tablet by mouth twice a day with morning and evening meals (for diabetes).a. Resident 6's once daily aspirin was not included on the MAR and was not administered as prescribed between 08/01/24 and 09/02/24. On 09/04/24 at 10:27 am, Staff 24 (Med Care Manager) confirmed there was not a discontinuation order for this medication; therefore, the medication was not administered as ordered.b. Resident 6's MAR was blank on the following occasions;* 08/05/24 - the evening doses of atorvastatin, lisinopril, and metformin;* 08/10/24 - the evening doses of atorvastatin, lisinopril, and metformin;* 08/13/24 - the evening doses of atorvastatin, lisinopril, and metformin; and* 08/28/24 - the evening doses of atorvastatin, lisinopril, and metformin.On 09/03/24 at 3:42 pm, Staff 24 and this surveyor reviewed Resident 6's medication supply and MAR for all blanks. Staff 24 was unable to verify if the orders were followed as prescribed.c. Resident 6's prescription for metformin directed staff to give the medication with morning and evening meals. According to the resident's MAR, the medication was administered at 9:00 am and 9:30 pm daily. On 09/03/24, Staff 24 at 3:15 pm and the resident at 12:26 pm confirmed the evening meal is consumed between 4:00 pm and 6:00 pm. Therefore, the resident's metformin was not being administered as prescribed.The need to ensure all medications were carried out as prescribed was reviewed with Staff 1 (ED) on 09/05/24 at 11:17 am. She acknowledged the findings.
2. Resident 5 was admitted to the facility in 12/2023 with diagnoses including including Parkinson's disease.Resident 5's 08/01/24 through 09/03/24 MARs, corresponding observation notes, and current physician's orders were reviewed.The resident had physician orders for the following medications dated 04/07/24:* Atorvastatin 40 mg - Take one tablet by mouth daily (for high cholesterol);* Remove lidocaine 4% patch from left hip at 8:00 pm (for pain); * Melatonin 3 mg - Take one tablet by mouth daily at bedtime (for sleep);* Rytary 36.25 mg/145 mg capsule - Take one capsule by mouth three times daily (for Parkinson's disease); and* Rytary 61.25 mg/245 mg capsule - Take one capsule by mouth three times daily (for Parkinson's disease). Records revealed the following medications were marked as "not recorded" on the following dates: * 08/10/24 - removal of lidocaine patch;* 08/13/24 - melatonin; * 08/17/24 - atorvastatin, melatonin, Rytary 36.25/145 mg and Rytary ER 61.25 mg/245 mg for 8:00 pm doses;* 08/23/24 - removal of lidocaine patch;* 09/01/24 - removal of lidocaine patch; and * 09/01/24 - Rytary 36.25 mg/145 mg and Rytary 61.25 mg/245 mg for 8:00 pm doses. During an interview on 09/04/24 at 1:25 pm, Staff 19 (Chief of Wellness) was unable to confirm if the medications had been administered. The need to ensure physician orders were carried out as prescribed was discussed with Staff 1 (ED) on 09/04/24 at 3:00 pm. The findings were acknowledged.
OAR 411-054-0055 (1) (f-h) Systems: Treatment OrdersRESIDENT 6:1. Actions taken to correct rule violations include:a) Received discontinue aspirin order. b) Ordered is followed as prescribed for atorvastain, lisinopril and metformin and MAR is initialed.c) Metformin is being administered as prescribed and MAR is initialed.2. System will be corrected so that the violation will not occur again by:o Medication Order and Administration Reviews: a) Daily, Weekly, and Monthly Audits: The facility will implement a process for daily, weekly, and monthly reviews of medication orders to ensure medications are administered exactly as prescribed. These reviews will verify that the Medication Administration Record (MAR) is initialed by the administering staff member immediately after each administration. Any discrepancies in MAR documentation will be addressed in real-time, with corrective actions taken as necessary.b) Verification of Physician Orders: A 3 check system for daily, weekly, and monthly reviews of medication orders will be put in place to ensure that all written and signed physician orders are accurately documented in each resident's record. The facility will maintain up-to-date records of physician orders and perform regular audits to ensure compliance with this requirement.o Medication Administration Practices: a) Change to Bubble Pack Administration Protocol: The facility will revise its medication administration practice by ensuring that Med Techs pop medications from the bubble pack based on the current date, rather than by sequence. This adjustment is intended to reduce the risk of medication errors and ensure that medications are administered in alignment with prescribed dosages and timing as suggested by state surveyors. Staff will be instructed to follow this new procedure starting Oct 10 (next cycle fill), and adherence will be monitored daily. o Staff Training on Medication Administration: a) Med Tech Training via Relias: All Med Techs will undergo mandatory medication administration training via the Relias platform, with a completion deadline of October 15, 2024. This training will cover proper procedures for administering medications, documentation protocols, and strategies for avoiding medication errors. Documentation of completed training will be submitted to the state surveyor no later than October 16, 2024.3. Ongoing Evaluation and Monitoring: a) Daily, Weekly, and Monthly Reviews: The effectiveness of these corrections will be evaluated through daily, weekly, and monthly audits conducted by the Administrator, RN, and/or designee. These audits will focus on ensuring that medications are being administered as prescribed, that the MAR is being appropriately updated, and that all physician orders are documented and verified.4. Accountability and Oversight: a) Responsible Party: The Administrator, RN, and/or designated staff will be responsible for ensuring that all corrections are implemented and maintained. Ongoing monitoring will be documented, and any identified issues will be addressed promptly with corrective actions tracked.5. Facility alleges compliance: October 20, 2024. except for: Medication Administration training for Mech Techs through Relias by 10/15/2024 and will provide training documentation to SQ no later than 10/16/2024RESIDENT 5:1. Actions taken to correct rule violations include:a) Lidocain patch is being removed as prescribed and MAR is initialed. b) Melatonin is being adminstered as prescribed and MAR is initialed.c) Atorvastatin is being administered as prescribed and MAR is initialed. 2. System will be corrected so that the violation will not occur again by:o Medication Order and Administration Reviews: a) Daily, Weekly, and Monthly Audits: The facility will implement a process for daily, weekly, and monthly reviews of medication orders to ensure medications are administered exactly as prescribed. These reviews will verify that the Medication Administration Record (MAR) is initialed by the administering staff member immediately after each administration. Any discrepancies in MAR documentation will be addressed in real-time, with corrective actions taken as necessary.o Staff Training on Medication Administration: a) Med Tech Training via Relias: All Med Techs will undergo mandatory medication administration training via the Relias platform, with a completion deadline of October 15, 2024. This training will cover proper procedures for administering medications, documentation protocols, and strategies for avoiding medication errors. Documentation of completed training will be submitted to the state surveyor no later than October 16, 2024.3. Ongoing Evaluation and Monitoring: a) Daily, Weekly, and Monthly Reviews: The effectiveness of these corrections will be evaluated through daily, weekly, and monthly audits conducted by the Administrator, RN, and/or designee. These audits will focus on ensuring that medications are being administered as prescribed, that the MAR is being appropriately updated, and that all physician orders are documented and verified.4. Accountability and Oversight: a) Responsible Party: The Administrator, RN, and/or designated staff will be responsible for ensuring that all corrections are implemented and maintained. Ongoing monitoring will be documented, and any identified issues will be addressed promptly with corrective actions tracked.5. Faility Alleges Compliance: October 20, 2024 except for Medication Administration training for Mech Techs through Relias by 10/15/2024 and will provide training documentation to SQ no later than 10/16/2024 .
Plan of Correction:
OAR 411-054-0055 (1) (f-h) Systems: Treatment OrdersRESIDENT 3:1. Actions taken to correct rule violations include:a) Metformin and Losartan meds have been reordered timely.b) Polyethylene glycol,Naprozen PRN, Hydrocodone acetaminophen PRN, Benzonatate PRN, and Fexofendine administered according to the latest physician orders.2. System will be corrected so that the violation will not occur again by:a) daily, weekly and monthly review ofmedication and treatment orders to ensure medications are administered as prescribed.b) daily, weekly, and monthly review of medication and treatment orders to ensure written, signed physician orders are documented in the resident's recordc) daily, weekly, and monthly review of medication and treatment orders to ensure resident's records are in alignment with signed physician's orders related to medication and treatments.3. Corrections will be evaluated daily, weekly and monthly.4. Administrator, Wellness Director (RN) and/or designee will be responsible for corrections to be completed and monitored.RESIDENT 1:1. Actions taken to correct rule violations include:a) Sertraline and azelastine nasal spray have a written, signed physican order documented in the resident 1's record.2. System will be corrected so that the violation will not occur again by:a) daily, weekly and monthly review of medication and treatment orders to ensure administeration and carry out as prescribed.b) daily, weekly, and monthly review of medication and treatment orders to ensure written, signed physician orders are documented in the resident's record.c) daily, weekly, and monthly review medication and treatment orders to ensure resident's records is align with signed physician's orders in related to medication and treatments.3. Corrections will be evaluated daily, weekly and monthly.4. Administrator, Wellness Director (RN) and/or designee will be responsible for corrections are to be completed and monitored.RESIDENT 2:1. Actions taken to correct rule violations include:a) Physician order list for Resident 2 is signed by PCP.b) Cranberry PAC, Estrace cream, Preservision gel, Acetaminophen, and Melatonin have a written, signed physican order documented in the resident 2's record.c) Baclofen TID, Cultrelle, Ezetimide, Modafinil, Preservision gels and Vitamin D3 are available to administer as prescibled by PCP.2. System will be corrected so that the violation will not occur again by:a) daily, weekly and monthly review of medication and treatment orders to ensure administeration and carry out as prescribed.b) daily, weekly, and monthly review of medication and treatment orders to ensure written, signed physician orders are documented in the resident's record.c) daily, weekly, and monthly review medication and treatment orders to ensure resident's records is align with signed physician's orders in related to medication and treatments.3. Corrections will be evaluated daily, weekly and monthly.4. Administrator, Wellness Director (RN) and/or designee will be responsible for corrections are to be completed and monitored.OAR 411-054-0055 (1) (f-h) Systems: Treatment OrdersRESIDENT 6:1. Actions taken to correct rule violations include:a) Received discontinue aspirin order. b) Ordered is followed as prescribed for atorvastain, lisinopril and metformin and MAR is initialed.c) Metformin is being administered as prescribed and MAR is initialed.2. System will be corrected so that the violation will not occur again by:o Medication Order and Administration Reviews: a) Daily, Weekly, and Monthly Audits: The facility will implement a process for daily, weekly, and monthly reviews of medication orders to ensure medications are administered exactly as prescribed. These reviews will verify that the Medication Administration Record (MAR) is initialed by the administering staff member immediately after each administration. Any discrepancies in MAR documentation will be addressed in real-time, with corrective actions taken as necessary.b) Verification of Physician Orders: A 3 check system for daily, weekly, and monthly reviews of medication orders will be put in place to ensure that all written and signed physician orders are accurately documented in each resident's record. The facility will maintain up-to-date records of physician orders and perform regular audits to ensure compliance with this requirement.o Medication Administration Practices: a) Change to Bubble Pack Administration Protocol: The facility will revise its medication administration practice by ensuring that Med Techs pop medications from the bubble pack based on the current date, rather than by sequence. This adjustment is intended to reduce the risk of medication errors and ensure that medications are administered in alignment with prescribed dosages and timing as suggested by state surveyors. Staff will be instructed to follow this new procedure starting Oct 10 (next cycle fill), and adherence will be monitored daily. o Staff Training on Medication Administration: a) Med Tech Training via Relias: All Med Techs will undergo mandatory medication administration training via the Relias platform, with a completion deadline of October 15, 2024. This training will cover proper procedures for administering medications, documentation protocols, and strategies for avoiding medication errors. Documentation of completed training will be submitted to the state surveyor no later than October 16, 2024.3. Ongoing Evaluation and Monitoring: a) Daily, Weekly, and Monthly Reviews: The effectiveness of these corrections will be evaluated through daily, weekly, and monthly audits conducted by the Administrator, RN, and/or designee. These audits will focus on ensuring that medications are being administered as prescribed, that the MAR is being appropriately updated, and that all physician orders are documented and verified.4. Accountability and Oversight: a) Responsible Party: The Administrator, RN, and/or designated staff will be responsible for ensuring that all corrections are implemented and maintained. Ongoing monitoring will be documented, and any identified issues will be addressed promptly with corrective actions tracked.5. Facility alleges compliance: October 20, 2024. except for: Medication Administration training for Mech Techs through Relias by 10/15/2024 and will provide training documentation to SQ no later than 10/16/2024RESIDENT 5:1. Actions taken to correct rule violations include:a) Lidocain patch is being removed as prescribed and MAR is initialed. b) Melatonin is being adminstered as prescribed and MAR is initialed.c) Atorvastatin is being administered as prescribed and MAR is initialed. 2. System will be corrected so that the violation will not occur again by:o Medication Order and Administration Reviews: a) Daily, Weekly, and Monthly Audits: The facility will implement a process for daily, weekly, and monthly reviews of medication orders to ensure medications are administered exactly as prescribed. These reviews will verify that the Medication Administration Record (MAR) is initialed by the administering staff member immediately after each administration. Any discrepancies in MAR documentation will be addressed in real-time, with corrective actions taken as necessary.o Staff Training on Medication Administration: a) Med Tech Training via Relias: All Med Techs will undergo mandatory medication administration training via the Relias platform, with a completion deadline of October 15, 2024. This training will cover proper procedures for administering medications, documentation protocols, and strategies for avoiding medication errors. Documentation of completed training will be submitted to the state surveyor no later than October 16, 2024.3. Ongoing Evaluation and Monitoring: a) Daily, Weekly, and Monthly Reviews: The effectiveness of these corrections will be evaluated through daily, weekly, and monthly audits conducted by the Administrator, RN, and/or designee. These audits will focus on ensuring that medications are being administered as prescribed, that the MAR is being appropriately updated, and that all physician orders are documented and verified.4. Accountability and Oversight: a) Responsible Party: The Administrator, RN, and/or designated staff will be responsible for ensuring that all corrections are implemented and maintained. Ongoing monitoring will be documented, and any identified issues will be addressed promptly with corrective actions tracked.5. Faility Alleges Compliance: October 20, 2024 except for Medication Administration training for Mech Techs through Relias by 10/15/2024 and will provide training documentation to SQ no later than 10/16/2024 .